Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05005026 · ClinicalTrials.gov registry record · NA

Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury

A NA study of Spinal Cord Injuries and Neuropathic Pain, sponsored by Texas A&M University.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
3
Study locations

NCT05005026 is a NA study of Spinal Cord Injuries and Neuropathic Pain that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 250 participants, above the 60-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (317% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05005026, a NA study of Spinal Cord Injuries and Neuropathic Pain, is actively recruiting participants, sponsored by Texas A&M University.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.

Interventions

  • OTHER VR Game 1
  • OTHER VR Game 2

Study Locations (3)

Alabama

  • University of Alabama at Birmingham - Birmingham

Texas

  • Texas A&M University - College Station

New South Wales

  • University of New South Wales - Sydney

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-11-23
Est. Completion 2026-09
Phase NA

Sponsor

Texas A&M University

95 total trials

What the Registry Record Tells You About NCT05005026

The ClinicalTrials.gov registry entry for NCT05005026 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 60-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (317% higher). The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which VR Game 1 is the first listed.

NCT05005026 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alabama, Texas, New South Wales.

Frequently Asked Questions

What is clinical trial NCT05005026 about?

NCT05005026 is a clinical study titled "Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury". The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.

What is the current status of trial NCT05005026?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-11-23. Estimated completion is 2026-09.

What conditions does trial NCT05005026 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Neuropathic Pain.

What interventions are being tested in trial NCT05005026?

The interventions under investigation include: VR Game 1 (OTHER), VR Game 2 (OTHER).

Who is sponsoring clinical trial NCT05005026?

This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05005026 being conducted?

This trial has 3 study locations across Alabama, Texas, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.